Evidence map›Paper›PMID 40349485›Full record

ArticleRedox biology2025

Sex- and age-dependent neurovascular abnormalities linked to neuroinflammation lead to exacerbated post-ischemic brain injury in Marfan syndrome mice.

Gemma Manich, Belén Pérez, Clara Penas, Ana Paula Dantas, Joana Coutinho, Paula Sánchez-Bernadó, Julián García-Aranda, Juan Fraile-Ramos, Núria Benseny-Cases, Beatriz Martín-Mur and 5 more

Abstract read
In one paragraph

Article in Redox biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Pain Hypersensitivity in a Mouse Model of Marfan Syndrome.Antioxidants (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Gemma ManichDepartment of Morphological Sciences, School of Medicine, Universitat Autònoma de Barcelona, Cerdanyola Del Vallès, Spain; Institute of Neurosciences, Universitat Autònoma de Barcelona, Cerdanyola Del Vallès, Spain.
Belén PérezInstitute of Neurosciences, Universitat Autònoma de Barcelona, Cerdanyola Del Vallès, Spain; Department of Pharmacology, Therapeutics, and Toxicology, School of Medicine, Universitat Autònoma de Barcelona, Cerdanyola Del Vallès, Spain.
Clara PenasInstitute of Neurosciences, Universitat Autònoma de Barcelona, Cerdanyola Del Vallès, Spain; Department of Cell Biology, Physiology and Immunology, Universitat Autonoma de Barcelona, Cerdanyola Del Vallès, Spain; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain; Red Española de Terapias Avanzadas (RED-TERAV), Instituto de Salud Carlos III, Madrid, Spain.
Ana Paula DantasDepartment of Biomedical Sciences, School of Medicine and Health Sciences, University of Barcelona, Institut D'Investigacions Biomediques August Pi I Sunyer, Hospital Clinic Cardiovascular Institute, Barcelona, Spain.
Joana CoutinhoInstitute of Neurosciences, Universitat Autònoma de Barcelona, Cerdanyola Del Vallès, Spain; Department of Pharmacology, Therapeutics, and Toxicology, School of Medicine, Universitat Autònoma de Barcelona, Cerdanyola Del Vallès, Spain.
Paula Sánchez-BernadóInstitute of Neurosciences, Universitat Autònoma de Barcelona, Cerdanyola Del Vallès, Spain; Department of Pharmacology, Therapeutics, and Toxicology, School of Medicine, Universitat Autònoma de Barcelona, Cerdanyola Del Vallès, Spain.
Julián García-ArandaInstitute of Neurosciences, Universitat Autònoma de Barcelona, Cerdanyola Del Vallès, Spain; Department of Pharmacology, Therapeutics, and Toxicology, School of Medicine, Universitat Autònoma de Barcelona, Cerdanyola Del Vallès, Spain; Instituto de Investigaciones Biomédicas de Barcelona-Consejo Superior de Investigaciones Científicas (IIBB-CSIC), Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain.
Juan Fraile-RamosInstitute of Neurosciences, Universitat Autònoma de Barcelona, Cerdanyola Del Vallès, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Núria Benseny-CasesUnitat de Biofísica. Department of Biochemistry and Molecular Biology, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Beatriz Martín-MurCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain.
Anna Esteve-CodinaCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain.
Isaac Rodríguez-RoviraDepartment of Biomedical Sciences, School of Medicine and Health Sciences, University of Barcelona-IDIBAPS, Barcelona, Spain.
Lydia Giménez-LlortInstitute of Neurosciences, Universitat Autònoma de Barcelona, Cerdanyola Del Vallès, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Gustavo EgeaDepartment of Biomedical Sciences, School of Medicine and Health Sciences, University of Barcelona-IDIBAPS, Barcelona, Spain; Department of Medical Genetics, University of Antwerpen, Antwerpen, Belgium.
Francesc Jiménez-AltayóInstitute of Neurosciences, Universitat Autònoma de Barcelona, Cerdanyola Del Vallès, Spain; Department of Pharmacology, Therapeutics, and Toxicology, School of Medicine, Universitat Autònoma de Barcelona, Cerdanyola Del Vallès, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: francesc.jimenez@uab.cat.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibrillin 1 gene (Fbn1) mutations cause Marfan syndrome (MFS), triggering life-threatening aortic complications and multi-organ effects. MFS is increasingly linked to neurovascular complications, amplified by aortic surgery risks. However, the impact of MFS on the brain remains unclear, including the roles of sex, aging, and their contribution to cerebral injury. This study examines brain alterations and their role in cerebral ischemic injury in an MFS mouse model. RNA-seq analysis of young (3-month-old) and aged (13-month-old) male and female wild-type and MFS (Fbn1

Indexed as

Brain IschemiaMarfan SyndromeNeuroinflammatory DiseasesAdipokinesAge FactorsAgingAnimalsBrainDisease Models, AnimalExtracellular MatrixFemaleFibrillin-1MaleMiceSex FactorsTransforming Growth Factor betaAdipokinesFbn1 protein, mouseFibrillin-1Transforming Growth Factor betaExtracellular matrixfibrillin 1Ischemic brain injuryMarfan syndromeNeuroinflammationNeurovascular complications

Identifiers

PMID40349485
PMCPMC12139021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.